Evidence map›Paper›PMID 41835439›Full record

ArticleFrontiers in public health2026

"We are ambassadors, we are advocates": rare disease patient advocacy groups as knowledge brokers across health and social systems-a qualitative study from Poland.

Jan Domaradzki

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jan DomaradzkiDepartment of Social Sciences and Humanities, Poznan University of Medical Sciences, Poznań, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rare diseases (RDs) pose a significant public health concern, particularly in Poland, where awareness among healthcare professionals, educators, and the general public remains low. Rare disease patient advocacy groups (RDPAGs), often led by caregivers, play a vital yet under recognized role in addressing these gaps through informal education and advocacy. This study explores how RDPAGs help fill systemic gaps in RD-related education. Methods: This qualitative descriptive study draws on 11 interviews with leaders of Polish RDPAGs engaged in advocacy, education, and public engagement. Interviews were analysed using Reflexive Thematic Analysis, following Braun and Clarke's six-phase framework, and reported in line with COREQ guidelines. Results: The analysis identified four interrelated themes describing the educational and advocacy practices of RDPAGs. Participants portrayed RDPAGs as: (1) acting as ambassadors of knowledge across sectors by translating scientific and experiential expertise into accessible information; (2) supporting families through lived experience by providing curated resources, peer mentoring, and practical guidance, particularly following diagnosis; (3) engaging with and sometimes challenging professional expertise by sharing caregiver-informed knowledge, co-developing materials, and initiating dialogue with healthcare and education professionals; and (4) raising public awareness and engaging in policy-oriented advocacy through campaigns and inter-organizational collaboration. Collectively, participants described these practices as addressing systemic knowledge gaps and supporting cross-sectoral care navigation. Conclusion: The findings indicate that healthcare, education, and policy systems in Poland already rely substantially on the informal educational and advocacy work of RDPAGs. Formal recognition and support may help stabilize these contributions, provided that issues of sustainability, role boundaries, and uneven organizational burdens are taken into account.

Indexed as

Patient AdvocacyRare DiseasesCaregiversFemaleHumansInterviews as TopicMalePolandQualitative Researchadvocacyawareness-raisingeducationexperiential knowledgeknowledge brokeragepatient advocacy groupspublic engagementrare disease patient advocacy groups

Identifiers

PMID41835439
PMCPMC12980798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.